ARBE vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

ARBE

46.9
AI Score
VS
ARBE Wins

MLAB

39.8
AI Score

Investment Advisor Scores

ARBE

47score
Recommendation
HOLD

MLAB

40score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ARBE MLAB Winner
Forward P/E 0 34.4828 Tie
PEG Ratio 0 0 Tie
Revenue Growth 156.6% 1.0% ARBE
Earnings Growth 0.0% -42.4% ARBE
Tradestie Score 46.9/100 39.8/100 ARBE
Profit Margin 0.0% 1.9% MLAB
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ARBE

Relative Price Performance (Last 90 Days)

ARBE 1M: -2.8% · 3M: -22.1% MLAB 1M: +1.5% · 3M: +29.2%

Current Technical Phase

ARBE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 41

RSI (14): 41.0 · Price: $0.61

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.3% over 20 days), RSI 59

RSI (14): 59.2 · Price: $132.55

Fundamentals Snapshot

Metric ARBE MLAB
Market Cap — —
Forward P/E -4.4 24.6
Trailing P/E — 153.9
Revenue (TTM) — —
Revenue Growth 1.6% 0.0%
Gross Margin -0.2% 0.6%
Operating Margin -14.0% 0.1%
EPS -0.33 0.84
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, ARBE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.